These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

662 related items for PubMed ID: 29843532

  • 1. Increased GOLM1 Expression Independently Predicts Unfavorable Overall Survival and Recurrence-Free Survival in Lung Adenocarcinoma.
    Liu X, Chen L, Zhang T.
    Cancer Control; 2018; 25(1):1073274818778001. PubMed ID: 29843532
    [Abstract] [Full Text] [Related]

  • 2. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma.
    Zhou S, Wang P, Su X, Chen J, Chen H, Yang H, Fang A, Xie L, Yao Y, Yang J.
    PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286
    [Abstract] [Full Text] [Related]

  • 3. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL, Gong Y, Zhao DP.
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [Abstract] [Full Text] [Related]

  • 4. Aberrant S100A16 expression might be an independent prognostic indicator of unfavorable survival in non-small cell lung adenocarcinoma.
    Chen D, Luo L, Liang C.
    PLoS One; 2018 Dec; 13(5):e0197402. PubMed ID: 29746588
    [Abstract] [Full Text] [Related]

  • 5. High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients.
    Xie L, Dang Y, Guo J, Sun X, Xie T, Zhang L, Yan Z, Amin H, Guo X.
    Genes (Basel); 2019 Jan 10; 10(1):. PubMed ID: 30634629
    [Abstract] [Full Text] [Related]

  • 6. UBE2D1 RNA Expression Was an Independent Unfavorable Prognostic Indicator in Lung Adenocarcinoma, but Not in Lung Squamous Cell Carcinoma.
    Hou L, Li Y, Wang Y, Xu D, Cui H, Xu X, Cong Y, Yu C.
    Dis Markers; 2018 Jan 10; 2018():4108919. PubMed ID: 30420903
    [Abstract] [Full Text] [Related]

  • 7. LDHA upregulation independently predicts poor survival in lung adenocarcinoma, but not in lung squamous cell carcinoma.
    Yu C, Hou L, Cui H, Zhang L, Tan X, Leng X, Li Y.
    Future Oncol; 2018 Oct 10; 14(24):2483-2492. PubMed ID: 29756998
    [Abstract] [Full Text] [Related]

  • 8. SPC25 upregulation increases cancer stem cell properties in non-small cell lung adenocarcinoma cells and independently predicts poor survival.
    Chen J, Chen H, Yang H, Dai H.
    Biomed Pharmacother; 2018 Apr 10; 100():233-239. PubMed ID: 29432994
    [Abstract] [Full Text] [Related]

  • 9. USP4 expression independently predicts favorable survival in lung adenocarcinoma.
    Zhong M, Jiang Q, Jin R.
    IUBMB Life; 2018 Jul 10; 70(7):670-677. PubMed ID: 29667299
    [Abstract] [Full Text] [Related]

  • 10. Expression of SUMO1P3 Compared with SUMO1 is an Independent Predictor of Patient Outcome in Lung Adenocarcinoma.
    Su X, Wan Y, Xie L, Lin X, Zhao H, Ju X, Fang A.
    Med Sci Monit; 2019 Sep 06; 25():6691-6701. PubMed ID: 31489957
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis.
    Gan BL, He RQ, Zhang Y, Wei DM, Hu XH, Chen G.
    Int J Oncol; 2018 Oct 06; 53(4):1557-1579. PubMed ID: 30066858
    [Abstract] [Full Text] [Related]

  • 12. The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC.
    Fu L, Wang H, Wei D, Wang B, Zhang C, Zhu T, Ma Z, Li Z, Wu Y, Yu G.
    PLoS One; 2020 Oct 06; 15(5):e0233283. PubMed ID: 32437446
    [Abstract] [Full Text] [Related]

  • 13. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma.
    Li L, Liu YD, Zhan YT, Zhu YH, Li Y, Xie D, Guan XY.
    Thorac Cancer; 2018 Jul 06; 9(7):775-784. PubMed ID: 29722145
    [Abstract] [Full Text] [Related]

  • 14. PLEK2 Gene Upregulation Might Independently Predict Shorter Progression-Free Survival in Lung Adenocarcinoma.
    Zhang W, Li T, Hu B, Li H.
    Technol Cancer Res Treat; 2020 Jul 06; 19():1533033820957030. PubMed ID: 33084541
    [Abstract] [Full Text] [Related]

  • 15. LncRNAs are altered in lung squamous cell carcinoma and lung adenocarcinoma.
    Liu B, Chen Y, Yang J.
    Oncotarget; 2017 Apr 11; 8(15):24275-24291. PubMed ID: 27903974
    [Abstract] [Full Text] [Related]

  • 16. Elevated expression of Twinfilin-1 is correlated with inferior prognosis of lung adenocarcinoma.
    Kaishang Z, Xue P, Shaozhong Z, Yingying F, Yan Z, Chanjun S, Zhenzhen L, Xiangnan L.
    Life Sci; 2018 Dec 15; 215():159-169. PubMed ID: 30391462
    [Abstract] [Full Text] [Related]

  • 17. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
    Li N, Li Y, Zheng P, Zhan X.
    Front Endocrinol (Lausanne); 2021 Dec 15; 12():755805. PubMed ID: 34745015
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y, Jiang L, Lin H, Li X, Long X, Zhou Y, Li B, Li Z.
    IUBMB Life; 2019 Jul 15; 71(7):942-955. PubMed ID: 30817091
    [Abstract] [Full Text] [Related]

  • 19. High Expression of FGF5 Is an Independent Prognostic Factor for Poor Overall Survival and Relapse-Free Survival in Lung Adenocarcinoma.
    Zhao T, Qian K, Zhang Y.
    J Comput Biol; 2020 Jun 15; 27(6):948-957. PubMed ID: 31553229
    [Abstract] [Full Text] [Related]

  • 20. Prognostic alternative mRNA splicing signature in non-small cell lung cancer.
    Li Y, Sun N, Lu Z, Sun S, Huang J, Chen Z, He J.
    Cancer Lett; 2017 May 01; 393():40-51. PubMed ID: 28223168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.